相互作用
Brexucabtagene autoleucel + Cladribine
重症度: 重大
Brexucabtagene autoleucel and Cladribine: major interaction.
最終更新日
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
概要
Cladribine depletes lymphocytes and may compromise collection, expansion, and activity of CAR-T cells. It also adds to the infection risk from immunosuppression.
この相互作用をわかりやすく説明すると
Brexucabtagene autoleucel and Cladribine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Brexucabtagene autoleucel belongs to Oncology; Cladribine belongs to Oncology.
なぜ起こるのか
Lymphotoxic effect of cladribine reduces T-cell numbers and function, affecting CAR-T manufacturing and expansion, and adds to immunosuppression.
対処法
Avoid cladribine before leukapheresis and CAR-T infusion, observing the washout interval in the product labeling. Monitor for infections if exposure has occurred.
薬剤師に尋ねること
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、Brexucabtagene autoleucelとCladribineの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
WebでPro+を14日間無料でお試し。カード登録不要。
Cladribineのその他の相互作用
Brexucabtagene autoleucelのその他の相互作用
よくある質問
Can I take Brexucabtagene autoleucel with Cladribine?
MediHelp rates the interaction as major. Brexucabtagene autoleucel and Cladribine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Cladribine depletes lymphocytes and may compromise collection, expansion, and activity of CAR-T cells. It also adds to the infection risk from immunosuppression.
How serious is the interaction between Brexucabtagene autoleucel and Cladribine?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid cladribine before leukapheresis and CAR-T infusion, observing the washout interval in the product labeling. Monitor for infections if exposure has occurred.
What other medicines interact with Cladribine?
MediHelp also lists interactions of Cladribine with, for example, Adenovirus types 4 and 7 live, Siponimod, Tofacitinib. The full list is on the Cladribine page.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
